Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | coagulation factor VII (serum prothrombin conversion accelerator) | Starlite/ChEMBL | References |
Homo sapiens | protease, serine, 2 (trypsin 2) | References | |
Homo sapiens | kallikrein B, plasma (Fletcher factor) 1 | Starlite/ChEMBL | References |
Homo sapiens | plasminogen activator, tissue | Starlite/ChEMBL | References |
Homo sapiens | protease, serine, 1 (trypsin 1) | References | |
Homo sapiens | plasminogen activator, urokinase | Starlite/ChEMBL | References |
Homo sapiens | protease, serine, 3 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | cercarial elastase (S01 family) | protease, serine, 3 | 261 aa | 234 aa | 25.2 % |
Brugia malayi | Trypsin family protein | protease, serine, 1 (trypsin 1) | 247 aa | 287 aa | 21.6 % |
Schistosoma mansoni | cercarial elastase (S01 family) | protease, serine, 2 (trypsin 2) | 247 aa | 240 aa | 25.8 % |
Echinococcus granulosus | glycoprotein Antigen 5 | coagulation factor VII (serum prothrombin conversion accelerator) | 466 aa | 384 aa | 23.7 % |
Echinococcus granulosus | Mastin | plasminogen activator, urokinase | 414 aa | 340 aa | 24.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | DNA repair protein, putative | 0.0105 | 0 | 0.5 |
Entamoeba histolytica | poly(ADP-ribose) polymerase, putative | 0.0808 | 0.9569 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0615 | 0.6941 | 1 |
Echinococcus granulosus | WGR domain containing protein | 0.0251 | 0.1982 | 0.1839 |
Trypanosoma cruzi | poly(ADP-ribose) polymerase, putative | 0.0444 | 0.461 | 1 |
Schistosoma mansoni | poly [ADP-ribose] polymerase | 0.0808 | 0.9569 | 1 |
Onchocerca volvulus | 0.0358 | 0.3442 | 1 | |
Schistosoma mansoni | poly [ADP-ribose] polymerase | 0.0384 | 0.3794 | 0.0574 |
Echinococcus multilocularis | poly (ADP ribose) polymerase 1 | 0.0808 | 0.9569 | 1 |
Echinococcus granulosus | poly ADP ribose polymerase 1 | 0.0808 | 0.9569 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0358 | 0.3442 | 0.4958 |
Trypanosoma brucei | poly(adp-ribose) polymerase | 0.0444 | 0.461 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0358 | 0.3442 | 0.4958 |
Echinococcus granulosus | poly adp ribose polymerase 2 | 0.0444 | 0.461 | 0.4666 |
Schistosoma mansoni | poly [ADP-ribose] polymerase | 0.0444 | 0.461 | 0.1906 |
Onchocerca volvulus | 0.0319 | 0.2913 | 0.8463 | |
Brugia malayi | WGR domain containing protein | 0.0444 | 0.461 | 0.1906 |
Trypanosoma cruzi | poly(ADP-ribose) polymerase, putative | 0.0444 | 0.461 | 1 |
Loa Loa (eye worm) | poly(ADP-ribose) polymerase | 0.0318 | 0.29 | 0.4179 |
Brugia malayi | WGR domain containing protein | 0.0808 | 0.9569 | 1 |
Echinococcus granulosus | poly (ADP ribose) polymerase | 0.0251 | 0.1982 | 0.1839 |
Echinococcus multilocularis | poly (adp ribose) polymerase 2 | 0.0444 | 0.461 | 0.4152 |
Leishmania major | hypothetical protein, conserved | 0.0105 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0444 | 0.461 | 0.6641 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 0.1 uM | The compound was tested for inhibition of human urokinase type plasminogen activator (microPa) | ChEMBL. | 11689072 |
Ki (binding) | = 0.1 uM | The compound was tested for inhibition of human urokinase type plasminogen activator (microPa) | ChEMBL. | 11689072 |
Ki (binding) | = 0.21 uM | The compound was tested for inhibition of human plasmin | ChEMBL. | 11689072 |
Ki (binding) | = 0.21 uM | The compound was tested for inhibition of human plasmin | ChEMBL. | 11689072 |
Ki (binding) | = 1.6 uM | The compound was tested for inhibition of human trypsin | ChEMBL. | 11689072 |
Ki (binding) | = 1.6 uM | The compound was tested for inhibition of human trypsin | ChEMBL. | 11689072 |
Ki (binding) | = 4.8 uM | The compound was tested for inhibition of human p-kallikrein | ChEMBL. | 11689072 |
Ki (binding) | = 4.8 uM | The compound was tested for inhibition of human p-kallikrein | ChEMBL. | 11689072 |
Ki (binding) | = 7 uM | The compound was tested for inhibition of human coagulation factor VII | ChEMBL. | 11689072 |
Ki (binding) | = 7 uM | The compound was tested for inhibition of human coagulation factor VII | ChEMBL. | 11689072 |
Ki (binding) | = 39 uM | The compound was tested for inhibition of human tissue plasminogen activator | ChEMBL. | 11689072 |
Ki (binding) | = 39 uM | The compound was tested for inhibition of human tissue plasminogen activator | ChEMBL. | 11689072 |
Ki (binding) | > 75 uM | Binding affinity against human coagulation factor X | ChEMBL. | 11689072 |
Ki (binding) | > 75 uM | The compound was tested for inhibition of human thrombin | ChEMBL. | 11689072 |
Ki (binding) | > 75 uM | Binding affinity against human coagulation factor X | ChEMBL. | 11689072 |
Ki (binding) | > 75 uM | The compound was tested for inhibition of human thrombin | ChEMBL. | 11689072 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.